PDF] BCDB ‐ A database for breast cancer research and information

Cancers, Free Full-Text

PDF) Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer

Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system

Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients

PDF) A Novel Prognostic Nomogram for 2-Year Survival in HER2-Positive Breast Cancer Patients

Compliance with multidisciplinary team recommendations and disease outcomes in early breast cancer patients: An analysis of 4501 consecutive patients - ScienceDirect

PDF) Do 21-Gene Recurrence Score Influence Chemotherapy Decisions in T1bN0 Breast Cancer Patients?

Frontiers Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment

Frontiers Molecular Subtype May Be More Associated With Prognosis and Chemotherapy Benefit Than Tumor Size in T1N0 Breast Cancer Patients: An Analysis of 2,168 Patients for Possible De-Escalation Treatment

Clinical characteristics and disease outcomes in ER+ breast cancer: a comparison between HER2+ patients treated with trastuzumab and HER2- patients, BMC Cancer